The British Journal of Psychiatry· 2026Q1
Psychotropic medications in mood disorders: to deprescribe or not?
- 1citations
- Q1SCImago
- 2026year
Short summary
New guidance offers expert consensus on deprescribing psychotropic medications for mood disorders, outlining strategies for clinical implementation.
AI-generated from the title and abstract; the full text is not read.
Key points
- Guidance for deprescribing psychotropic medications in mood disorders has been developed through expert consensus.
- The guidance offers suggestions for clinical implementation of deprescribing strategies.
- The paper discusses the execution of these strategies in different clinical settings.
- Integration of deprescribing into routine clinical practice is also addressed.
AI-generated from the title and abstract; the full text is not read.
Abstract
In recent years deprescribing mood disorder medications has attracted increasing attention, and guidance provides suggestions for clinical implementation of deprescribing strategies that have been derived through expert consensus. Summarising and highlighting key recommendations, we discuss their execution in various clinical contexts and discuss their integration into clinical practice.
The authors' abstract, as published at the source. The British Journal of Psychiatry, 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pharmacology (Medicine)
PharmacologyMedicine